Charles Y Lin

19PUBLICATIONS

196CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer cell biologyInnate immunityCell physiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Jun 24, 2026

Anti-Tumor Activity of Cdk2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide Refractory Neuroblastoma.

|Nov 17, 2025

Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma.

W Frank Lenoir, Michael R McKeown, Giulia Giorgetti

|Aug 08, 2025

Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer.

Nicholas J Neill, Shankha Satpathy, Karsten Krug

|Aug 28, 2024

MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer.

Jitendra K Meena, Jarey H Wang, Nicholas J Neill

|Mar 06, 2023

CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma.

Yao Yao, Jessica Fong Ng, Woojun Daniel Park

|Sep 20, 2022

A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth.

Eugenio Morelli, Mariateresa Fulciniti, Mehmet K Samur

Pageof 4

Frequent Collaborators

Nathanael S Gray

Woojun Daniel Park

James E Bradner

Richard A Young

Behnam Nabet

Eugenio Morelli

Carolina Gutierrez

Jinpeng Sun

Rocio Dominguez-Vidana

2 joint publications

Louis Chesler

Frequent Collaborators

Nathanael S Gray

Woojun Daniel Park

James E Bradner

Richard A Young